Some stocks are lagging the market for good reasons -- because their businesses look shaky and their prospects uncertain.

Members of the Our Place Parkinson’s support group learned about a newly approved therapy offering more consistent symptom ...

Medtronic (MDT) ended the recent trading session at $82.90, demonstrating a +0.44% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.81%.

The federal appellate court rejected an out-of-state employee's Minnesota Human Rights Act claims against her former ...

Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

Truist lowered the firm’s price target on Medtronic (MDT) to $90 from $93 and keeps a Hold rating on the shares as part of a broad research ...

Medtronic PLC closed 14.24% short of its 52-week high of $96.25, which the company reached on March 10th.

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

Eden Prairie students Milan Darji and Vick Tan were among the winners at the recent State Science & Engineering Fair.

A fired Medtronic USA Inc. senior director is unable to sue the company for disability discrimination under Minnesota law ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...